Your browser doesn't support javascript.
loading
Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial.
de Steur, W O; van Amelsfoort, R M; Hartgrink, H H; Putter, H; Meershoek-Klein Kranenbarg, E; van Grieken, N C T; van Sandick, J W; Claassen, Y H M; Braak, J P B M; Jansen, E P M; Sikorska, K; van Tinteren, H; Walraven, I; Lind, P; Nordsmark, M; van Berge Henegouwen, M I; van Laarhoven, H W M; Cats, A; Verheij, M; van de Velde, C J H.
Affiliation
  • de Steur WO; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Amelsfoort RM; Department of Radiation Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Hartgrink HH; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Grieken NCT; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
  • van Sandick JW; Department of Surgical Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Claassen YHM; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Braak JPBM; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Jansen EPM; Department of Radiation Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Sikorska K; Department of Biometrics, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • van Tinteren H; Department of Biometrics, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Walraven I; Department of Radiation Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Lind P; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Nordsmark M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • van Berge Henegouwen MI; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, the Netherlands.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, the Netherlands.
  • Cats A; Department of Gastrointestinal Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Verheij M; Department of Radiation Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van de Velde CJH; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: C.J.H.van_de_Velde@lumc.nl.
Ann Oncol ; 32(3): 360-367, 2021 03.
Article in En | MEDLINE | ID: mdl-33227408
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy, Adjuvant Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy, Adjuvant Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido